Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · IEX Real-Time Price · USD
10.07
-0.31 (-2.99%)
At close: Jul 19, 2024, 4:00 PM
10.02
-0.05 (-0.50%)
Pre-market: Jul 20, 2024, 9:28 AM EDT
Inovio Pharmaceuticals Revenue
Inovio Pharmaceuticals had revenue of $717.07K in the twelve months ending March 31, 2024. In the year 2023, Inovio Pharmaceuticals had annual revenue of $832.01K.
Revenue (ttm)
$717.07K
Revenue Growth
-92.95%
P/S Ratio
363.87
Revenue / Employee
$5,878
Employees
122
Market Cap
260.92M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 832.01K | -9.43M | -91.89% |
Dec 31, 2022 | 10.26M | 8.49M | 478.23% |
Dec 31, 2021 | 1.77M | -5.64M | -76.05% |
Dec 31, 2020 | 7.41M | 3.30M | 80.24% |
Dec 31, 2019 | 4.11M | -26.37M | -86.51% |
Dec 31, 2018 | 30.48M | -11.74M | -27.80% |
Dec 31, 2017 | 42.22M | 6.85M | 19.37% |
Dec 31, 2016 | 35.37M | -5.20M | -12.83% |
Dec 31, 2015 | 40.57M | 30.12M | 288.00% |
Dec 31, 2014 | 10.46M | -3.01M | -22.35% |
Dec 31, 2013 | 13.47M | 9.35M | 226.98% |
Dec 31, 2012 | 4.12M | -5.68M | -57.95% |
Dec 31, 2011 | 9.80M | 3.65M | 59.41% |
Dec 31, 2010 | 6.14M | -2.98M | -32.62% |
Dec 31, 2009 | 9.12M | 7.02M | 334.78% |
Dec 31, 2008 | 2.10M | -2.71M | -56.37% |
Dec 31, 2007 | 4.81M | 1.34M | 38.62% |
Dec 31, 2006 | 3.47M | -2.00M | -36.56% |
Dec 31, 2005 | 5.47M | 4.30M | 368.45% |
Dec 31, 2004 | 1.17M | 1.09M | 1,349.29% |
Dec 31, 2003 | 80.53K | -108.99K | -57.51% |
Dec 31, 2002 | 189.52K | -4.10M | -95.58% |
Mar 31, 2001 | 4.29M | -786.15K | -15.48% |
Mar 31, 2000 | 5.08M | -3.24M | -38.98% |
Mar 31, 1999 | 8.32M | 4.66M | 127.43% |
Mar 31, 1998 | 3.66M | 499.41K | 15.81% |
Feb 28, 1997 | 3.16M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Auna SA | 1.08B |
MultiPlan | 959.44M |
Procaps Group | 414.10M |
Viemed Healthcare | 194.05M |
Nektar Therapeutics | 90.17M |
Sanara MedTech | 68.00M |
INO News
- 10 days ago - INO-3107 Awarded the Innovation Passport Designation Under U.K. Government's Innovative Licensing and Access Pathway - PRNewsWire
- 19 days ago - INOVIO Announces Appointment of Steven Egge as Chief Commercial Officer - PRNewsWire
- 20 days ago - INOVIO Reports Inducement Grant Under Inducement Plan - PRNewsWire
- 20 days ago - INOVIO Added to Russell 2000® Index Effective July 1, 2024 - PRNewsWire
- 6 weeks ago - INOVIO to Participate in Virtual Fireside Chat Hosted by Stephens Inc. - PRNewsWire
- 7 weeks ago - INOVIO Reports Inducement Grants Under Inducement Plan - PRNewsWire
- 2 months ago - INOVIO Reports First Quarter 2024 Financial Results and Recent Business Highlights - PRNewsWire
- 2 months ago - INOVIO to Participate in Upcoming Investor Conferences in May - PRNewsWire